Novo Nordisk a/s
Novo Nordisk A/S is the parent of the Novo Nordisk group, a global healthcare company.
🤖
AI Overview
With $30K in lobbying spend across 8 quarterly filings, Novo Nordisk a/s is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2024 to 2025.
$30K
Total Spend
2
Years Active
1
Firms Hired
6
Lobbyists Deployed
2
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2024 | $30K |
| 2025 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Manufacturing
- •Manufacturing capacity and supply chain resiliency.
- •Issues related to manufacturing capacity and supply chain resiliency.
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Medline, Formerly Reported as Medline Industries, LP
$6.0M total spend
University of Pittsburgh
$5.8M total spend
Itg Brands, LLC (Formerly Fontem US, INC.)
$5.4M total spend
Accendra Health, INC. (Formerly "owens & Minor, INC.")
$4.3M total spend
Beone Medicines USA, INC (Formerly Beigene USA, INC.)
$3.5M total spend
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.